Zeev's Turnips Patch-No Politics (ZEEV)

[butterfly111]

AMGN is up today due to this upgrade

"Amgen "outperform"

Monday, May 08, 2006 7:42:37 AM ET
Robert W. Baird

NEW YORK, May 8 (newratings.com) - Analysts at Robert W Baird reiterate their "outperform" rating on Amgen Inc (AMGN.NAS). The target price is set to $90.

In a research note published this morning, the analysts mention that a recent nephrologists survey indicated that the company’s Aranesp drug continues to gain share in the CKD market. Aranesp’s growth prospects are bright, with the surveyed nephrologists projecting an increase in the drug’s market share from 48.7% to 52.4% over the next six months, the analysts say. The drug is unlikely to face substantial competition from CERA, Robert W Baird adds."

http://www.newratings.com/analyst_news/article_1268834.html